The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
Official Title: A Prospective Clinical Registry Study of Genetic Profiling and Targeted Therapies in Patients With Rare Cancers in ASIA
Study ID: NCT05217407
Brief Summary: This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing. The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
National Cancer Center Hospital, Japan, Chuo-ku, Tokyo, Japan
National Cancer Center Korea, Seoul, , Korea, Republic of
Hospital Sultan Ismail, Johor Bahru, Johor, Malaysia
Hospital Pulau Pinang, Pulau Pinang, Penang, Malaysia
Sarawak General Hospital, Kuching, Sarawak, Malaysia
Hospital Kuala Lumpur, Kuala Lumpur, , Malaysia
University Malaya Medical Center, Kuala Lumpur, , Malaysia
Institut Kanser negara, Putrajaya, , Malaysia
St. Luke's Medical Center, Manila, , Philippines
National Taiwan University Hospital, Taipei, Zhongzheng, Taiwan
Taipei Veterans General Hospital, Taipei, , Taiwan
Mahidol University by Faculty of Medicine, Ramathibodi Hospita, Bangkok, , Thailand
Mahidol University by Faculty of Medicine, Siriraj Hospital, Bangkok, , Thailand
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, , Thailand
Faculty of Medicine, Prince of Songkla University, Hat Yai, , Thailand
Khon Kaen University by Faculty of Medicine, Srinagarind Hospital, Khon Kaen, , Thailand
National Cancer Vietnam, Hanoi, , Vietnam
Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, , Vietnam
Name: Noboru Yamamoro, MD, PhD
Affiliation: National Cancer Center Hospital, Japan
Role: PRINCIPAL_INVESTIGATOR
Name: Kan Yonemori, MD, PhD
Affiliation: National Cancer Center Hospital, Japan
Role: STUDY_DIRECTOR
Name: Kenichi Nakamura, MD, PhD
Affiliation: National Cancer Center Hospital, Japan
Role: STUDY_DIRECTOR
Name: Yuta Maruki, MD
Affiliation: National Cancer Center Hospital, Japan
Role: STUDY_DIRECTOR
Name: Takuji Okusaka, MD, PhD
Affiliation: National Cancer Center Hospital, Japan
Role: PRINCIPAL_INVESTIGATOR